Skip to main content
. 2024 Feb 25;115(4):1296–1305. doi: 10.1111/cas.16107

FIGURE 3.

FIGURE 3

Best percentage change in sum of longest diameters in Japanese patients with METex14 skipping NSCLC*. (A) Treatment‐naïve patients, (B) Previously treated patients. *One treatment‐naïve and one previously treated patient are not shown due to baseline/on‐treatment measurements not being available. PD, progressive disease; PR, partial response; SD, stable disease.